Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Clinical trial NCT03879694 · COMPLETED

Trial details

NCT number: NCT03879694
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Atypical Carcinoid Tumor Lung Typical Carcinoid Tumor Metastatic Pancreatic Neuroendocrine Tumor

Start date: 2019-06-17
Primary completion: 2025-02-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.